Phase I Clinical Trial of COVID-19 mRNA Vaccine in Adults Aged 18 Years and Older

PHASE1CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

May 17, 2022

Primary Completion Date

August 8, 2022

Study Completion Date

August 8, 2022

Conditions
COVID-19
Interventions
BIOLOGICAL

COVID-19 mRNA vaccine

2 doses of vaccine on Day 0 and Day 21

BIOLOGICAL

Placebo

2 doses of placebo on Day 0 and Day 21

Trial Locations (3)

Unknown

Beijing Friendship Hospital, Beijing

Hebei Petro China Center Hospital, Langfang

Hunan Provincial Center for Disease Control and Prevention, Changsha

Sponsors
All Listed Sponsors
lead

CanSino Biologics Inc.

INDUSTRY

NCT05373485 - Phase I Clinical Trial of COVID-19 mRNA Vaccine in Adults Aged 18 Years and Older | Biotech Hunter | Biotech Hunter